186 related articles for article (PubMed ID: 12198609)
1. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
3. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
[TBL] [Abstract][Full Text] [Related]
5. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
Eckle T; Jahn G; Hamprecht K
J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
[TBL] [Abstract][Full Text] [Related]
6. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
Limaye AP
Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
[TBL] [Abstract][Full Text] [Related]
7. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
8. Human beta-herpesvirus interactions in solid organ transplant recipients.
Mendez JC; Dockrell DH; Espy MJ; Smith TF; Wilson JA; Harmsen WS; Ilstrup D; Paya CV
J Infect Dis; 2001 Jan; 183(2):179-184. PubMed ID: 11120923
[TBL] [Abstract][Full Text] [Related]
9. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
Humar A; Kumar D; Boivin G; Caliendo AM
J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
[TBL] [Abstract][Full Text] [Related]
12. An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O; Pang XL; Humar A; Kumar D; Doucette K; Preiksaitis JK
J Infect Dis; 2009 Jun; 199(11):1621-8. PubMed ID: 19385736
[TBL] [Abstract][Full Text] [Related]
13. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively.
Baldanti F; Sarasini A; Silini E; Barbi M; Lazzarin A; Biron KK; Gerna G
Scand J Infect Dis Suppl; 1995; 99():103-4. PubMed ID: 8668930
[TBL] [Abstract][Full Text] [Related]
14. [Resistance of cytomegalovirus to ganciclovir: rapid detection of the mutations 460 of the UL97 phosphotransferase].
Alain S; Mazeron MC; Vadam C; Honderlick P; Thouvenot D; Freymuth F; Fillet AM; Carquin J; Sanson-Le Pors MJ
Pathol Biol (Paris); 1996 May; 44(5):456-60. PubMed ID: 8758494
[TBL] [Abstract][Full Text] [Related]
15. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
[TBL] [Abstract][Full Text] [Related]
16. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K
Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760
[TBL] [Abstract][Full Text] [Related]
17. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
Gilbert C; LeBlanc MH; Boivin G
Herpes; 2001 Nov; 8(3):80-2. PubMed ID: 11867025
[TBL] [Abstract][Full Text] [Related]
18. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
19. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus.
Liu JB; Zhang Z
J Virol Methods; 2008 Apr; 149(1):129-35. PubMed ID: 18280587
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]